Concepedia

New hope for treatment of respiratory involvement following COVID-19 by bromhexine

Abdolrazagh Barzegar, Masoud Ghadipasha, Nima Rezaei, Mehdi Forouzesh, Rohollah Valizadeh

Journal of Nephropharmacology · 2020 · 28 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Bromhexine as a fluidifying agent can be investigated in clinical trials to discover its therapeutic effect on respiratory involvement following COVID-19.

References

5

Kidney disease is associated with in-hospital death of patients with COVID-19

Yichun Cheng, Ran Luo, Kun Wang et al. · Kidney International · 2020 · 2.9K citations · Full text

, , +11

Pharmacology and Pharmacotherapeutics.

Annals of Internal Medicine · 1972 · 185 citations

, , +10

Determination of ambroxol or bromhexine in pharmaceuticals by capillary isotachophoresis

Marie Pospı́šilová, Miroslav Polášek, V. Jokl · Journal of Pharmaceutical and Biomedical Analysis · 2001 · 59 citations

, , +6

Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.

C C Roa, R B Dantes · PubMed · 1995 · 19 citations

, , +15

A SARS-CoV-2 Prophylactic and Treatment; A Counter Argument Against The Sole Use of Chloroquine

Markus Depfenhart · American Journal of Biomedical Science & Research · 2020 · 13 citations · Full text

, , +17